Andrew Callos insider trades: Cytokinetics (CYTK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Andrew reports to the SEC
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | CYTK | ↓ Sell | 10,000 | $70.24 | $702K | Direct | Aug 31, 2026 (0d) |
| Jul 30, 2026 | CYTK | ↓ Sell | 14,000 | $79.88 | $1.1M | Direct | Jul 30, 2026 (0d) |
| Jul 1, 2026 | CYTK | ↓ Sell | 15,000 | $85.80 | $1.3M | Direct | Jul 2, 2026 (1d) |
| May 5, 2026 | CYTK | ↓ Sell | 11,333 | $77.25 | $875K | Direct | May 5, 2026 (0d) |
| Apr 30, 2026 | CYTK | ↓ Sell | 15,000 | $63.26 | $949K | Direct | Apr 30, 2026 (0d) |
| Mar 31, 2026 | CYTK | ↓ Sell | 3,639 | $65.00 | $237K | Direct | Mar 31, 2026 (0d) |
| Mar 18, 2026 | CYTK | ↓ Sell | 1,930 | $62.07 | $120K | Direct | Mar 18, 2026 (0d) |
| Mar 17, 2026 | CYTK | ↓ Sell | 8,542 | $62.15 | $531K | Direct | Mar 18, 2026 (1d) |
| Mar 16, 2026 | CYTK | ↓ Sell | 1,709 | $61.03 | $104K | Direct | Mar 16, 2026 (0d) |
| Mar 9, 2026 | CYTK | ↓ Sell | 2,582 | $60.72 | $157K | Direct | Mar 10, 2026 (1d) |
| Mar 5, 2026 | CYTK | ↓ Sell | 26,000 | $61.87 | $1.6M | Direct | Mar 5, 2026 (0d) |
| Mar 2, 2026 | CYTK | ↓ Sell | 886 | $61.62 | $55K | Direct | Mar 2, 2026 (0d) |
| Feb 5, 2026 | CYTK | ↓ Sell | 15,000 | $61.93 | $929K | Direct | Feb 5, 2026 (0d) |
| Feb 2, 2026 | CYTK | ↓ Sell | 886 | $62.10 | $55K | Direct | Feb 2, 2026 (0d) |
| Jan 5, 2026 | CYTK | ↓ Sell | 15,000 | $60.28 | $904K | Direct | Jan 5, 2026 (0d) |
| Jan 2, 2026 | CYTK | ↓ Sell | 1,798 | $62.62 | $113K | Direct | Jan 2, 2026 (0d) |
| Dec 8, 2025 | CYTK | ↓ Sell | 1,042 | $65.96 | $69K | Direct | Dec 8, 2025 (0d) |
| Dec 5, 2025 | CYTK | ↓ Sell | 52,486 | $65.95 | $3.5M | Direct | Dec 5, 2025 (0d) |
| Jun 5, 2025 | CYTK | ↓ Sell | 8,659 | $32.04 | $277K | Direct | Jun 5, 2025 (0d) |
| May 5, 2025 | CYTK | ↓ Sell | 4,002 | $36.68 | $147K | Direct | May 5, 2025 (0d) |
| Apr 7, 2025 | CYTK | ↓ Sell | 2,886 | $35.78 | $103K | Direct | Apr 7, 2025 (0d) |
| Mar 17, 2025 | CYTK | ↓ Sell | 20,900 | $45.14 | $943K | Direct | Mar 17, 2025 (0d) |
| Mar 17, 2025 | CYTK | ↓ Sell | 2,775 | $44.38 | $123K | Direct | Mar 17, 2025 (0d) |
| Mar 14, 2025 | CYTK | ↓ Sell | 100 | $45.00 | $5K | Direct | Mar 14, 2025 (0d) |
| Mar 13, 2025 | CYTK | ↓ Sell | 26,771 | $43.62 | $1.2M | Direct | Mar 13, 2025 (0d) |
| Mar 6, 2025 | CYTK | ↓ Sell | 3,341 | $43.27 | $145K | Direct | Mar 7, 2025 (1d) |
| Mar 3, 2025 | CYTK | ↓ Sell | 1,114 | $42.88 | $48K | Direct | Mar 5, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CYTK insiders
Open-market trades in the last 12 months
About Andrew Callos's insider trades
Andrew Callos is EVP, Chief Commercial Officer at Cytokinetics (CYTK). Since Mar 3, 2025, Andrew has reported no open-market purchases and 27 sales worth $16.2M on SEC Form 4. In the last 12 months: 18 sales ($13.3M).
Their filings also include option exercises (15 filings), grants and awards (8 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.